IN-VITRO ASSESSMENT AND COMPARISON OF ANTIOXIDANT EFFECTS OF AZITHROMYCIN WITH ITS SILVER AND GOLD NANO CONJUGATED FORM Authors: ZEHRA D , MEMON Z, JABEEN A, ISMAIL K, USMAN S, AND AGHA F
ABSTRACT
Oxidative stress is usually associated with the release of reactive oxygen species (ROS) involved
in various pathological conditions going on inside the body. Azithromycin is a macrolide
antibiotic recommended commonly for the treatment of upper respiratory infections, also acts as
an active anti-inflammatory and antioxidant agent so might be beneficial in chronic
inflammatory states other than infectious disease. However, at the same time it produces
oxidative damages to several organs of the body due to unwanted penetration. The aim of this
study is to identify suppressive role of azithromycin on ROS generation in human blood cells via
chemiluminescence assay and to compare this effect with its silver and gold conjugated nano
form. We have found that azithromycin suppressed ROS generation at the concentration between
250 ?g/ml and 500 ?g/ml (IC50 =310.8?g/ml). However, the maximum effect was observed
with silver nanoparticle (AgNp) conjugated form of azithromycin which showed maximum
effect at comparatively lower concentration (between 25?g/ml and 100?g/ml with IC50 value of 34.8?g/ml) while gold nano particle (AuNp) conjugated form remain insignificant for
antioxidant activity. Although antioxidative ability is related to azithromycin alone but when it
was conjugated to AgNp could lead to higher antioxidant activity in lower concentration.
Therefore, the results of our studies support the antioxidant effects of azithromycin enhanced to
significant levels when conjugated with silver nanoparticle as compare to azithromycin alone.
Keywords: Azithromycin, antioxidant effects, Gold and silver conjugation Publication date: 01/01/2020 https://ijbpas.com/pdf/2020/January/MS_IJBPAS_2019_4930.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2020/9.1.4930